DAFTAR PUSTAKA

1. Kuntz E, Kuntz H-D. Morphology of The Liver. In Kuntz E, Kuntz H-D.

Hepatology Principles and Practice. 2nd ed. Heidelberg: Springer Medizin Verlag.
2006; 2:14-20
2. Ghany M, Hoofnagle JH. Approach to Patient with Liver Disease. In Kasper DL, et
al. editors. Harrisons Principles of Internal Medicine. 16th ed., New York: The
McGraw- Hill Companies, Inc. 2005; P. 1808-1812
3. Fasel JHD, et al. Macroscopic Anatomy of The Liver. In Rods J, et al. editors.
Textbook of Hepatology, 3rd ed., Massachusetts: Blackwell Publishing Ltd. 2007;
P. 3-7
4. Hansen JT, Lambert DR. Viscera: Liver. In Hansen JT, Lambert DR. Netters
Clinical Anatomy, 1st ed., Maryland: MediMedia, Inc. 2005
5. Wang XW, et al. Biology of Hepatocelular Carcinoma: Past, Present and Beyond.
In Wang XW, et al. editors. Molecular Genetics of Liver Neoplasia. Springer, New
York, 2011; P 3-18
6. Dancygier H. Gross Anatomy In Dancygier H. Clinical Hepatology Principles
and Practice of Hepatobiliary Diseases Vol.1. Springer-Verlag, Berlin, 2010; P 1114
7. Kuntz E, Kuntz H-D. Morphology of the Liver. In Kuntz E, Kuntz H-D.
Hepatology Textbook and Atlas. 3rd ed. Springer Medizin Verlag, 2008; P 16-21
8. Lee W-C, Chen M-F. Epidemiology, Etiology, and Natural History of
Hepatocellular Carcinoma. In Clavien P-A, et al. editors. Malignant Liver Tumors,
3rd ed., Chichester: Blackwell Publishing Ltd. 2010; P 52-54
9. Leong TY-M, Leong AS-Y. Epidemiology. In Lau WY. editor. A Book on
Hepatocellular Carcinoma, 1st ed., Singapore: World Scientific Publishing Co. Pte.
Ltd. 2008; P 1-24
10. White DL, et al. Epidemiology of Hepatocellular Carcinoma. In Carr BI. editor.
Hepatocellular Carcinoma Diagnosis and Treatment, 2nd ed., New York, Humana
Press. 2010; P 1-26
11. Usatoff V, Habib NA. Hepatocellular Carcinoma The Clinical Problem. In Habib
NA. editor. Methods in Molecular Medicine, vol.45: Hepatocellular Carcinoma
Methods and Protocol, Humana Press Inc., Totowa; P 3-20
12. Wasmuth J-C. Hepatitis B Epidemiology, Transmission and Natural History, In
Mauss S, et al. editors. Hepatology A Clinical Textbook, 2nd ed., Flying
Publisher, Dsseldorf, 2010; P 7-18

13. Marrero JA. Epidemiology of Hepatocellular Carcinoma and Cholangiocarcinoma.

In Hussain HK, Francis IR. editors: Primary Carcinomas of The Liver, Cambridge
University Press, Cambridge, 2010; P 1-9
14. Hassan MM, Kaseb AO. Epidemiology and Pathogenesis of Hepatocellular
Carcinoma. In McMasters KM, Vauthey J-N. editors. Hepatocellular Carcinoma
Targeted Therapy and Multidisciplinary Care, Springer, New York, 2011; P 1-20
15. Roberts LR, Gores GJ. Hepatocellular Carcinoma. In Yamada T, et al. editors:
Textbook of Gastroenterology, 5th ed., Blackwell Publishing Ltd., Chichester,
2009; P 2386-2390
16. Shulz WA. Liver Cancer. In Schulz WA. editor, Molecular Biology of Human
Cancer An Advanced Students Textbook. Springer, Dordrecht, 2005; P 327-336
17. Dancygier H. Hepatocellular Carcinoma. In Dancygier H. Clinical Hepatology
Principles and Practice of Hepatobiliary Diseases Vol.2. Springer-Verlag, Berlin,
2010; P 1307-1312; 1317-1325
18. Teytelboym O, et al. Pancreatic and Hepatobiliary Cancers. In Wahl RL. editor.
Principles and Practice of PET and PET/CT. 2nd ed. Lippincott Williams and
Wilkins, Philadelphia, 2009; P 340-343
19. Weishaupt D, Hany TF. Modalities for Imaging Liver Tumors. In Clavien P-A, et
al. editors: Malignant Liver Tumors, 3rd ed., Chichester: Blackwell Publishing Ltd.
2010; P 76-100
20. BabaY, et al. Liver: Helical Computed Tomography and Magnetic Resonance
Imaging. In Methods of cancer Diagnosis, Therapy, and Prognosis Vol.5 Liver
Cancer. Hayat MA. editor, Springer, 2009; P 33-42
21. Fung KTT, et al. Systematic Review of Radiological Imaging for Hepatocellular
Carcinoma in Cirrhotic Patients. The British Journal of Radiology 77 (2004), 633
640
22. Li KCP. Molecular Imaging. In Hepatocellular Carcinoma Screening, Diagnosis,
and Management, Natcher Conference Center National Institutes of Health
Bethesda. Maryland. 2004; P 109-111
23. Delbeke D, Walker RC. Hepatobiliary and Pancreatic Malignancies. In Delbeke D,
Israel O. editors. Hibrid PET/CT and SPECT/CT Imaging A Teaching File.
Springer, New Yorl, 2010; P 331-336
24. Delbeke D, Pinson CW. 11C-Acetate: A New Tracer for the Evaluation of
Hepatocellular Carcinoma. J Nucl Med. 2003 Feb;44(2):222-3
25. Ho C-L, et al. 11C-Acetate PET Imaging in Hepatocellular Carcinoma and Other
Liver Mass. J Nucl Med. 2003 Feb;44(2):213-21.
26. Yamamoto Y, et al. Detection of Hepatocellular Carcinoma Using
PET: Comparison with 18F-FDG PET. J Nucl Med 2008; 49:12451248

11C-Choline

27. Ho C-L, et al. Dual Tracer PET/CT Imaging in Evaluation of Metastatic

Hepatoccellular Carcinoma. J Nucl Med June 2007 vol. 48 no.6 902-909
28. Liu C-H, et al. Diagnostic Imaging Pre- and Post-ablation. In Adam A, Mueller PR.
editors. Interventional Radiological Treatment of Liver Tumors, 1st ed., Cambridge
University Press, Cambridge, 2009: P 1-24
29. Curley S, Siperstein AE. Radiofrequency Ablation of Hepatocellular Carcinoma. In
Ellis LM, et al. editors. Radiofrequency Ablation for Cancer Current Indications,
Techniques, and Outcomes. 1st ed., Springer-Verlag New York, Inc., 2004; P 1-30
30. Curley SA. Radiofrequency Ablation of Malignant Liver Tumors. The Oncologist
2001;6:14-23
31. Salmi A, et al. Efficacy of radiofrequency Ablation of Hepatocellular Carcinoma
Associated with Chronic Liver Disease without Cirrhosis. Int. J. Med. Sci. 2008, 5
32. Lencioni R, et al. Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis:
Long-term Results of Percutaneous Image-guided Radiofrequency Ablation.
Radiology2005; 234: 961-967
33. Livraghi T, et al. Small Hepatocellular Carcinoma: Treatment with Radiofrequency
Ablation versus Ethanol Injection. Radiology 1999;210:655-661
34. Li C-X, et al. Analysis of clinical effect of high-intensity focused ultrasound on
liver cancer. World J Gastroenterol 2004; 10(15): 2201-2204
35. Patel J. Liver Tumors (Hepatocellular Cancer). In Kessel DO, Ray CE. editors.
Transcatheter Embolization and Therapy, Springer, London, 2010; P 185-196
36. Wu F, et al. Advanced Hepatocellular Carcinoma: Treatment with High-Intensity
Focused Ultrasound Ablation Combined with Transcatheter Arterial Embolization.
Radiology 2005; 235:659667
37. Zhu AX. Hepatocellular Carcinoma. In Chabner BA, et al. Harrisons Manual of
Oncology. The McGraw-Hill Companies, Inc., 2008; P 410-416
38. Fukumoto T, Ku Y. Induction Chemotherapy for Hepatocellular Carcinoma. In
Aigner KR, Stephens FO. editors. Induction Chemotherapy Integrated Treatment
Programs for Locally Advanced Cancers. Springer-Verlag, Berlin, 2011; P 237-242
39. Barbare J-C, et al. Randomized Controlled Trial of Tamoxifen in Advanced
Hepatocellular Carcinoma. J Clin Oncol 2005 23:4338-4346
40. Kouroumalis E, et al. Treatment of Hepatocellular Carcinoma with Octreotide: A
Randomised Controlled Study. Gut. 1998 42(3):4427
41. Becker G, et al. Long-acting Octreotide Versus Placebo for Treatment of Advanced
HCC: A Randomized Controlled Double-blind Study. Hepatology. 2007 Jan
45(1):9-15
42. Lin AY, et al. Phase II Study of Thalidomide in Patients with Unresectable
Hepatocellular Carcinoma. Cancer 2005 103:11925

43. Patt YZ, et al. Thalidomide in the Treatment of Patients with Hepatocellular
Carcinoma -A Phase II Trial. Cancer 2005 103:74955
44. Zhu AX, et al. A Phase II Study of Epirubicin and Thalidomide in Unresectable or
Metastatic Hepatocellular Carcinoma. The Oncologist 2005 10:392398
45. Lai CL, et al. Recombinant Interferon-alpha in Inoperable Hepatocellular
Carcinoma: A Randomized Controlled Trial. Hepatology 1993 Mar 17(3):389-94
46. Llovet JM, et al. Randomized Controlled Trial of Interferon Treatment for
Advanced Hepatocellular Carcinoma. Hepatology 2000 31:54-58
47. Zhu AX, et al. Efficacy, Safety, and Potential Biomarkers of Sunitinib
Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study. J Clin
Oncol 27:3027-3035
48. Wilhelm SC, et al. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity
and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved
in Tumor Progression and Angiogenesis. DOI:10.1158/0008-5472.CAN-04-1443
49. Cheng AL, et al. Efficacy and Safety of Sorafenib in Patients in the Asia-Pacific
Region with Advanced Hepatocellular Carcinoma: A Phase III Randomised,
Double-blind, Placebo-controlled Trial. Lancet Oncol. 2009 Jan 10(1):25-34
50. Thomas MB, et al. Phase 2 Study of Erlotinib in Patients with Unresectable
Hepatocellular Carcinoma. Cancer. 2007 Sep 1 110(5):1059-67
51. Goin JE, et al. Treatment of Unresectable Hepatocellular Carcinoma with
Intrahepatic Yttrium-90-Microspheres: Factors Associated with Liver Toxicities. J
Vasc Interv Radiol. 2005 Feb 16(2 Pt 1):205-13
52. Salem R, et al. Treatment of Unresectable Hepatocellular Carcinoma with Use of
90Y

Microspheres (TheraSphere): Safety, Tumor Response, and Survival. J Vasc

Interv Radiol. 2005 Dec 16(12):1627-39

53. Kulik LM, et al. Safety and Efficacy of

90Y

Radiotherapy for Hepatocellular

Carcinoma With and Without Portal Vein Thrombosis. Hepatology 2008 47:71-81
54. Giammarilel F, et al. EANM Procedure Guideline for the Treatment of Liver
Cancer and Liver Metastases with Intra-arterial Radioactive Compounds. Eur J
Nucl Med Mol Imaging 2011 Jul;38(7):1393-406
55. Price. A,Wilson. L. M. Tuberkulosis Paru. Dalam: Patofisiologi Konsep
KlinisProses-Proses Penyakit, bab 4, Edisi VI. Jakarta: EGC, 2004 : 852-64.
56. Amin Z, Bahar S. Tuberkulosis paru. Dalam: Sudoyo AW, Setiyohadi B, Alwi I
,Simadibrata KM, Setiati S. Buku Ajar Ilmu Penyakit Dalam. Jilid II, Edisi IV.
Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI , 2006: 9981005, 1045-9.3.
57. NN. Pedoman Nasional Penanggulangan Tuberkulosis. 1 Maret 2009. Available
fromhttp://www.tbindonesia.or.id/pdf/BPN_2007.pdf 4.

58. Mansjoer.A, dkk. Tuberkulosis Paru. Dalam : Kapita selekta kedokteran,

cetakanke-7, Jakarta : Media Aesculapius, 2005 : 427-476.
59. Kabo
P.
Pengobatan
TBC.
1
Maret
2014.

Available,

from

http://www.medicastore.com/med/index.php
60. Wallace RJ,Griffith DE.Antimycobacterial Agents.In : Kasper DL, Fauci AS,Longo
DL,

Braunwald

E,Hauser

SL,

Jameson

JL.

Harrison's

Principles

of

InternalMedicine. Volume I. 16th Edition. McGraw-Hill. New York. 2005 : 946-53.

61. Aditama, T.Y. Tuberkulosis Diagnosis, Terapi & Masalahnya. Edisi IV. Jakarta
:Ikatan Dokter Indonesia (IDI), 2002.
62. Zevitz EM.Monitoring for During Antituberculosis Treatment . 25 Juli
2009.Available From:www.chp.gov.hk/files/pdf/grp-monitoring - for hepatotoxicit - during -antituberculosis -0 treatm-en-2004052100.pdf
63. Mansjoer.A, dkk. Tuberkulosis Paru. Dalam : Kapita selekta kedokteran,
cetakanke-7, Jakarta : Media Aesculapius, 2005 : 427-476.
64.